Acquirer
Abbvie Inc.
Abbvie Inc. appears as the named buyer in 3 recorded transactions between 2015 and 2024, most often in healthcare & life sciences.
Record
What Abbvie Inc. has bought
Every recorded transaction where Abbvie Inc. is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Celsius Therapeutics | Healthcare & Life Sciences | — | 2024-06-27 | $250m |
| Landos | Healthcare & Life Sciences | — | 2024-03-25 | $138m |
| Rare Pediatric Disease Priority Review Voucher (PPRV) | Healthcare & Life Sciences | United Therapeutics | 2015-08-19 | $350m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.